Lorem ipsum dolor sit amet, consectet eiusmod tempor incididunt ut labore e rem ipsum dolor sit amet. sum dolor sit amet, consectet eiusmod.
Mon - Fri: | 8:00 am - 8:00 pm |
Saturday: | 9:00 am - 6:00 pm |
Sunday: | 9:00 am - 6:00 pm |
Renal angiomyolipoma (AML) is a noncancerous (benign) tumor that forms in the kidney. It’s the most common type of benign kidney tumor, but it’s still relatively rare, affecting about 0.2% to 0.6% of the population.
What is it made of?
An AML is a unique tumor because it’s composed of three different types of tissue:
Many people with AML have no symptoms at all. The tumors are often discovered incidentally during imaging tests performed for other reasons. However, if the tumor grows large, it can cause some problems, including:
There are two main situations where AML can occur:
Imaging tests are the mainstay of diagnosing AML. These tests can help visualize the tumor and determine its size, location, and characteristics. Common imaging tests used for AML diagnosis include:
In most cases, no treatment is necessary for AML. Doctors typically recommend active surveillance, which involves monitoring the tumor with periodic imaging tests to watch for any signs of growth.
However, treatment may be considered in some situations, such as:
Treatment options for AML include: